menu
    • menu

    Company profile for Bone Biologics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development. Currently finalizing pivotal animal studies Clearance to move into human studies in Australia Potential commercialization into $3 billion dollar orthobiol...
    Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development. Currently finalizing pivotal animal studies Clearance to move into human studies in Australia Potential commercialization into $3 billion dollar orthobiologics market pending successful completion of pivotal human studies in U.S

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bone BiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Burlington Woods Drive, Suite 100 Burlington, MA 01803
    Telephone
    Telephone
    781-552-4452
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bonebiologics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bone Biologics CEO Shares Update and Outlook With Stockholders
    Bone Biologics CEO Shares Update and Outlook With Stockholders

    04 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250904789999/en/Bone-Biologics-CEO-Issues-Letter-to-Stockholders-Highlighting-Company-Update-and-Outlook

    BUSINESSWIRE
    04 Sep 2025
    Share Share
    Bone Bio to Participate in H.C. Wainwright Investment Conference
    Bone Bio to Participate in H.C. Wainwright Investment Conference

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903959890/en/Bone-Biologics-to-Participate-in-the-H.C.-Wainwright-Global-Investment-Conference

    BUSINESSWIRE
    03 Sep 2025
    Share Share
    Bone Biologics Patents Bone Regeneration Technology
    Bone Biologics Patents Bone Regeneration Technology

    27 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250627795812/en/Bone-Biologics-Files-Patent-Application-for-Bone-Regeneration-Technology

    BUSINESSWIRE
    27 Jun 2025
    Share Share
    Bone Biologics Regains Nasdaq Listing Compliance
    Bone Biologics Regains Nasdaq Listing Compliance

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626668160/en/Bone-Biologics-Regains-Compliance-with-Nasdaq-Continued-Listing-Requirements

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    Bone Biologics Appoints Robert E. Gagnon to Board of Directors
    Bone Biologics Appoints Robert E. Gagnon to Board of Directors

    11 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240111829711/en

    BUSINESSWIRE
    11 Jan 2024
    Share Share
    Bone Biologics Announces 1-for-8 Reverse Stock Split
    Bone Biologics Announces 1-for-8 Reverse Stock Split

    18 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231218953908/en

    BUSINESSWIRE
    18 Dec 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search